FDA recall D-1449-2016

Teva North America · Class III · drug

Product

Divalproex Sodium Delayed-release Tablets USP, RX, 250 mg, 100 count bottles, Manufactured in Israel by: TEVA PHARMACEUTICALS IND. LTD. Jerusalem, 9777402, Israel, Manufactured for: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454, NDC 0093-7440-01.

Reason for recall

Failed Tablet/Capsule Specifications

Distribution

Nationwide and Puerto Rico

Key facts

Status
Terminated
Initiation date
2016-05-18
Report date
2016-08-03
Termination date
2017-01-17
Voluntary/Mandated
Voluntary: Firm initiated
Location
Horsham, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1449-2016